Background: The 6-min walk distance (6MWD) is widely used to evaluate functional capacity in patients with chronic obstructive pulmonary disease (COPD). Aim: To examine predictors for longitudinal change in 6MWD including self-reported physical activity, smoking habits, body composition, exacerbations, comorbidity and lung function. Methods: The cohort included 389 patients aged 44e75 years, with clinically stable COPD in GOLD stages IIeIV. The follow-up time was 3 years. Measurements included 6MWD, spirometry, fat and fat free mass index (FMI and FFMI), and assessment of physical activity, smoking habits, comorbidities and exacerbations by questionnaires. Generalized estimating equations (GEE) regression analyses were used to analyze predictors for the change in 6MWD. Results: There was a reduction in 6MWD from baseline to 3 years for patients in GOLD stages III and IV (B Z À36 m, 95% CI Z À51 to À7, p Z 0.009 and B Z À79 m, CI Z À125 to À20, p Z 0.007). The unadjusted GEE analysis demonstrated that baseline self-reported physical activity level, forced expiratory volume in one second (FEV 1 ), forced vital capacity, FFMI, GOLD stages and age predicted change in 6MWD, but in the adjusted GEE analysis only self-reported physical activity level (p Z 0.001) and FEV 1 (p Z 0.019) predicted change over time. Respiratory Medicine (2014) 108, 86e94 Conclusion: Patients in GOLD stage II maintained their functional capacity assessed by 6MWD over 3 years, while it was significantly reduced for patients in GOLD stages III and IV. Level of physical activity and FEV 1 were predictors for longitudinal change in functional capacity. ª
Introduction
Exercise intolerance is the main factor limiting participation in activities of daily living in patients having chronic obstructive pulmonary disease (COPD) [1] . The degree of exercise intolerance is related to disease severity and is a result of complex interactions between ventilatory mechanical impairment, limitations of gas exchange, peripheral muscle function and symptoms [1, 2] . Functional capacity in COPD is most commonly measured with the 6min walk test (6MWT) and the distance walked in six minutes (6MWD) used as the primary outcome [3, 4] . Improvement in the 6MWD has been demonstrated after participation in a pulmonary rehabilitation program [5] . Physical training is a corner stone in rehabilitation programs and improves aerobic capacity and health related quality of life. [1] Maintaining the benefits requires continued training which may be a challenge for these patients when outside organized training programs. The improved functional capacity after a rehabilitation program has shown to be transient and has declined 1e2 years after rehabilitation [6] .
The natural long-term changes in 6MWD in COPD patients, not recruited through a pulmonary rehabilitation program or assessment for surgery, have been examined in four previous studies, with follow-up times between one and five years [7e10] . The mean annual decline in 6MWD varied between 2 and 40 m per year [7e10]. In the Eclipse study [10] , the change in 6MWD was related to age, gender, body mass index (BMI) and lung function by the Global Initiative for Chronic Obstructive Lung Disease [11] (GOLD) stage. The patients had no restriction receiving prescribed medication or other therapies during the study period, including rehabilitation, and such interventions were not registered. The effect of habitual physical activity was not assessed in any of these studies. The aim of the present study was to examine predictors for the longitudinal change in the 6MWD. We hypothesized that high habitual physical activity is associated with a lower longitudinal decline in 6MWD, and included self-reported physical activity, lung function, smoking habits, body composition, exacerbations and comorbidity in the analysis.
Methods

Study population
Of 433 patients with clinically stable COPD from the Bergen COPD Cohort Study (2006e2010), 389 patients aged 44e75 years completed the 6MWT at baseline and were included in the current study. The follow-up time was three years ( Fig. 1 ). Selection of the study population and the inclusion and exclusion criteria have been described in detail previously [12] . In brief, all patients were diagnosed with COPD, had a smoking history of !10 pack years, a postbronchodilation forced expiratory volume in one second (FEV 1 )/forced vital capacity (FVC) ratio <0.7 and a postbronchodilation FEV 1 <80% of predicted value according to Norwegian reference values [13] . Exacerbations that required medical treatment during the last four weeks prior to inclusion, led to deferment of inclusion. Patients with inflammatory disorders like rheumatoid arthritis, systemic lupus erythematosus or other connective tissue disorders, inflammatory bowel disease, and any active cancer in the last five years were excluded. Common chronic diseases with known inflammatory components like chronic heart disease, diabetes and hypertension were not a cause for exclusion.
The Bergen COPD Cohort Study, in which the patients were a subsample of the ECLIPSE study [14] , made no restrictions to treatment in the study period, and the participants were therefore free to receive medication and therapies, including rehabilitation, prescribed by their physician. In the Bergen COPD Cohort Study additional information on treatment and habitual physical activity during the study period was registered, which was not part of the ECLIPSE study. Of the 389 patients that completed 6MWT at baseline, 89 had participated in a pulmonary rehabilitation program during the study period, all of them within the first two years of the observation period. The rehabilitation program lasted for 7 weeks, and consisted of 17 sessions, each lasting for about 5.5 h.
Ethics
The study was approved by the Western Norway Regional Research Ethics Committee. Participation in the study was voluntary. Written and oral information was given, and written consent was obtained prior to the inclusion.
Assessment tools
Six-min walk test The 6MWT [4] was performed at baseline and after one and three years after inclusion in the study. The 6MWD was used as the primary outcome measure of functional capacity. The test was performed indoor, along a 30 m flat, straight enclosed corridor, according to the American Thoracic Society (ATS) guidelines [3] . A trained technician supervised the patients. The test was performed once each time, and a practice 6MWT was not done. Oxygen saturation (SpO 2 ) and heart rate (HR) were measured before and at the end of the test using a pulseoxymeter (NONIN Medical Inc., Plymouth, MN). The patients graded their level of dyspnea and fatigue by the Borg CR 10 scale [15] at the beginning and at the end of the test, and the 6MWD was registered. The use of oxygen during the test was registered.
Self-reported physical activity
Self-reported physical activity was recorded at baseline and after one and three years. There were two questions related to spare time physical activity, one for light and one for hard physical activity. The delineation between the two was whether the activity resulted in breathlessness and sweating or not. The response categories were none, less than 1 h per week, 1e2 h per week and three or more hours per week. These questions are validated [16, 17] and have been used in a large Norwegian general population study [18] .
Body composition, spirometry, dyspnea and Charlson index for comorbidities
Height and body mass were measured. The patients underwent bioelectrical impedance measurements of fat mass and fat free mass (Bodystat 1500, Isle of Man, England) after an overnight fast. The body mass index (BMI) was calculated as the body mass divided by the square of height, the fat free mass index (FFMI) as the fat free mass divided by the square of height, and the fat mass index (FMI) as the fat mass divided by the square of height [19] . Spirometry, both pre-and post-inhalation of 0.4 mg salbutamol, was conducted on a Viasys Masterscope (Viasys, Hoechberg, Germany). The spirometer was calibrated twice daily with a 3-L calibration syringe. The modified Medical Research Council (mMRC) dyspnea scale [20] was used to measure symptoms of dyspnea. Charlson index for comorbidities was determined from the information registered by the physician during the clinical examination at baseline [21] .
Statistics
Descriptive statistics were used to characterize the study population (mean and standard deviation (SD) and percent). Independent t-tests were used to compare continuous variables and chi square-tests for categorical variables across gender. Generalized estimating equations (GEE) regression analyses [22] with robust standard errors were used to identify potential predictors for the longitudinal change in 6MWD per year. An unstructured working correlation structure was applied to adjust for withinpatient correlation. Time was modeled as both a categorical variable (baseline, year 1, and year 3) and a continuous variable when longitudinal change in 6MWD was analyzed. The variables examined at baseline were age, gender, number of exacerbations 12 months prior to inclusion, FEV 1 , FVC, FMI, FFMI, pack years, Charlson index for comorbidities and self-reported physical activity. Continuous predictor variables were centered at their mean values to obtain interpretable regression coefficients: Age at 64 years, FEV 1 at 1.5 l, FVC at 3.3 l, and FMI at 8.4 kg/m 2 , FFMI at 17.0 kg/m 2 and pack years at 40.9 pack years. Interaction terms between each of the predictor variables and time were included to investigate the effects of these variables on change in 6MWD during follow-up. For unadjusted estimates, we calculated one GEE analysis for each predictor variable, which included the variable, time and the interaction term of variable and time. For the adjusted GEE analysis, we fitted a model where all the predictor variables and time and the interaction terms of variable and time were included in the model. Analysis for multicollinearity between FEV 1 and FVC, and between FMI and FFMI did not indicate multicollinearity, therefore all predictor variables, except GOLD stages were included in the same analysis. A possible confounder could be participation in rehabilitation during the study period. Separate GEE analysis with adjustment for participation in rehabilitation was done. In addition, we did separate GEE analysis for patients who did and did not participate in rehabilitation according to examine predictors for longitudinal change in 6MWD.
Multivariate logistic regression was applied to assess predictors for physical activity at 3 years follow-up with adjustment for participation in pulmonary rehabilitation (yes/no), age, gender, number of exacerbations 12 months prior to inclusion FEV 1 , FVC, FMI, FFMI, pack years and Charlson index for comorbidities.
Self-reported light and hard physical activity had four possible response categories, but in the GEE analysis and in the multivariate logistic regression, we transformed it to two response categories for both light and hard physical activity (no activity/light physical activity and no activity/ hard physical activity).
Estimated regression coefficients are presented with 95% confidence intervals (CI) and p-values. The significance level was set at 0.05. The data analyses were performed using IBM SPSS Statistics 20 (SPSS Inc. Chicago, Illinois, USA).
Results
Of the 389 patients who completed the baseline 6MWT, 319 (82%) and 264 (68%) completed the test at year 1 and 3 respectively ( Fig. 1) . At baseline, 13 (3.3%) patients used oxygen during the 6MWT, and at 1 and 3 years follow-up 11 (3.4%) and 10 (3.8%) did so. Baseline characteristics of the population are presented in Table 1 . The patients' mean age was 64 AE 7 years, 61% were males and mean FEV 1 in percent of predicted value was 49 AE 14%. According to GOLD stage, 179 (46%) patients were in stage II, 169 (43%) in stage III, and 41 (11%) in stage IV.
There was no significant difference in baseline characteristics, including 6MWD, between patients participating in pulmonary rehabilitation during the study period and non-participants. The dropout rates were 10% and 20%, and 20% and 36% at 1 and 3 years follow-up in those who did and did not participate in rehabilitation respectively. The fraction of subjects performing hard physical activity at three years was higher in those who had participated in a rehabilitation program, odds ratio 2.4 (95% CI 1.4e4.2, p Z 0.001) ( Table 2 ).
Longitudinal change in 6MWD
There were no differences in effort during the 6MWTs. The adjusted GEE analysis showed that the differences in SpO 2 , HR and Borg score between measurements immediately before and immediately after the 6MWT were not significantly different at any time.
The distribution of the individual change in 6MWD from baseline to 3 years is shown in Fig. 2 . The median reduction was 16 m. Estimated unadjusted mean 6MWD at baseline and after 1 and 3 years was 423 (95% CI: 412e434), 431 (95% CI: 419e433) and 400 (95% CI: 385e415) meters, respectively. The decrease in 6MWD from baseline to 3 years was statistically significant (B Z À23, 95% CI: À34 to À12, p < 0.001). The decrease over time in 6MWD was only evident for patients in GOLD stage III (B Z À36, 95% CI: À51 to À7, p Z 0.009) and in GOLD stage IV (B Z À79 m, 95% CI: À125 to À20, p Z 0.007) ( Fig. 3 ).
Predictors for longitudinal change in 6MWD
The unadjusted GEE analysis demonstrated that baseline habitual hard physical activity, FEV 1 , FVC, GOLD stage, FFMI and age were predictors for change in 6MWD, but in the adjusted GEE analysis only hard physical activity and FEV 1 predicted change in 6MWD. Yearly change in 6MWD for performing regular hard physical activity was positive, 3.9 m per year (p Z 0.001), and for FEV 1 it was positive, 12.4 m per year per liter increase in FEV 1 (p Z 0.019) ( Table 3 ). When excluding patients who used oxygen during the 6MWT, the results from the adjusted GEE analysis was the same as when all the patients were included in the analysis. When separate GEE analyses were done for patients who did and did not participate in rehabilitation, hard physical activity and FEV 1 remained as significant predictors for change in 6MWD.
Discussion
The main findings of the study were 1) Patients in GOLD stage II maintained their 6MWD during the follow-up period of 3 years, while it was significantly reduced in patients in GOLD stages III and IV.
2) The predictors at baseline for longitudinal change in 6MWD were self-reported hard physical activity and FEV 1 . 3) Patients that had participated in a pulmonary rehabilitation program during the study period reported a higher physical activity level at 3 years.
In normal subjects and in patients with mild COPD the 6MWD is biomechanically limited by their maximal walking speed rather than by their ventilatory capacity. This could be a reason why the patients in GOLD stage II maintained their 6MWD over 3 years. Some of the COPD patients had a 6MWD not different from the normal population. Both Casanova et al. [7] and Spruit et al. [10] demonstrated that 6MWD declined over time, but this finding was only significant in patients with severe airflow limitation. Even though there was a decline in 6MWD in our study for patients in GOLD stage III and IV, and the other follow-up studies [7, 9, 10] , the mean annual change in 6MWD was less than the minimal clinically important change that has been estimated to be 54 m. [23] . The patients in our study were a subsample of the larger ECLIPSE study. The results with respect to the longitudinal change in 6MWD were consistent [10] . However, Kapella et al. [8] found the 6MWD to be stable during a follow-up period of three years.
To our knowledge, this is the first study to report that physical activity was a significant predictor for change in 6MWD. The analyses showed that reporting hard physical activity at baseline influenced the longitudinal change in 6MWD positively. At 3 years follow-up, the fraction of subjects reporting regular hard physical activity was higher compared to baseline, and patients who had participated in pulmonary rehabilitation during the study period did so more often than the others did. Physical training does not improve the FEV 1 [24] , but it does improve skeletal-muscle function and endurance [24] . Dynamic hyperinflation has been demonstrated to be reduced when exercising regularly, which leads to mitigation in dyspnea [25] . High intensity training at an intensity of at least 60% of maximal exercise tolerance is necessary to achieve improvements in physical performance [1] . Our results demonstrated that only subjects reporting hard physical activity had an effect on the 6MWD.
The activity in our study was self-reported and thereby subject to bias by overestimation. The correlation between physical activity reported by questionnaire and objectively assessed activity by accelerometer has been shown to be weak [26] . However, a moderate correlation between selfreported physical activity and 6MWD was demonstrated by Walker et al. [26] and Nguyen et al. [27] Troosters et al. [28] measured physical activity objectively with an activity monitor for a period of 5e7 days in a group of cystic fibrosis patients. Moderate physical activity was related to peak oxygen uptake and quadriceps force, but not to 6MWD. Activity monitors are more accurate than self-reported questionnaire, but monitoring is usually done for shorter periods only, and awareness of the ongoing monitoring may increase activity level above the habitual. Rehabilitation may have a similar effect on awareness with respect to physical activity. Rehabilitation took place in the first year of the observation period for most patients. The effect of rehabilitation wanes over time [6] , and such an effect will probably be small at 3 years. FEV 1 was the other significant predictor for change in 6MWD. Spruit et al. [10] found that age and baseline body weight predicted change in 6MWD, while there was a differential effect of GOLD stage. We could not find that age and body mass index influenced the longitudinal change in 6MWD. GOLD stages are related to FEV 1 , which was a significant predictor in our study. Ventilatory capacity is related to maximal expiratory flow rates and FEV 1, and ventilatory capacity will at some point be the limiting factor for exercise performance. It is reasonable then, to find an association between 6MWD and FEV 1 . There is an association between maximal exercise tests and walking tests [29, 30] like the 6MWT and the Shuttle walk test [31] in COPD patients, and reduced maximal and functional exercise tests are both related to reduced ventilatory capacity.
Methodological considerations
The Bergen COPD-cohort study excluded patients with inflammatory disorders like rheumatoid arthritis, while patients with common chronic diseases with known inflammatory components like chronic heart disease, diabetes and hypertension were included in the study. The comorbidity could be thought to influence the longitudinal change in 6MWD. However, comorbidity was not a predictor of change in 6MWD. In a general COPD population, especially among patients in GOLD stages III or IV, other chronic diseases are common. We assume that our study population is representative for the common COPD patients met in outpatient clinics or in hospitals. Because of limited resources, 6MWT was only performed once on each occasion in our study, even though two tests are recommended according to ATS guidelines [3] . The learning effect is a bias in the 6MWT and to reduce it, two tests are preferred [3] . In the study of Hernandes et al. [32] the learning effect between first and second test resulted in an increase in 6MWD of 27 m. The tests were performed on two consecutive days. Our subjects increased their 6MWD from baseline to 1 year. It is possible that a learning effect could hide a natural decline in the 6MWD over this period, but it is more unlikely that the effect could last for 3 years. The changes in SpO 2 , HR and Borg score were not different from baseline to 1 year or from baseline to 3 years for any GOLD stages. This could indicate that the patients' effort was the same at baseline, 1-year and 3 years follow-up.
Study population
Among patients included in the study, the distribution according to GOLD stages were 179 patients in GOLD stage II, 169 in stage III and 41 in stage IV. There were fewer patients with more serious disease state as represented by GOLD stage IV. The explanation might be that the most severely ill patients were not able to participate in the study because of limited functional capacity. This finding is similar to other studies [8, 10] . However, the majority of our patients were in GOLD stages III and IV. The dropout rate from baseline to 3 years was 32%. The patients were lost to follow-up mostly because of death or increased disease severity. Kapella et al. [8] and Spruit et al. [10] also had a study period of 3 years and the dropout rates in these studies were 31%. Casanova et al. [7] had a follow-up period of 5 years, and the dropouts during the study period was 34%. COPD is a progressive disease and in long-term studies, an increasing dropout rate is unavoidable. In this respect, our results are in accordance with previous studies. The dropout rate was higher in those who did not participate in pulmonary rehabilitation. The explanation is probably that the most severely ill patients were not able to participate in pulmonary rehabilitation.
Conclusion
Our findings demonstrated that patients in GOLD stage II maintained their functional capacity assessed by 6MWD over 3 years, while it was significantly reduced for patients in GOLD stages III and IV. Level of habitual physical activity and FEV 1 were predictors for longitudinal change in functional capacity. The level of physical activity was higher at three years in subjects who had participated in a rehabilitation program during the observation period. The prevention of further reduction in lung function, if possible, and implementation of physical training programs seem to be important for maintaining functional capacity over time in COPD patients.
